KG19 Polyclonal Antibody

    • Catalog No.:YT2466
    • Applications:WB;IHC;IF;ELISA
    • Reactivity:Human;Mouse
      • Target:
      • KG19
      • Gene Name:
      • BRI3BP
      • Protein Name:
      • BRI3-binding protein
      • Human Swiss Prot No:
      • Q8WY22
      • Mouse Swiss Prot No:
      • Q8BXV2
      • Immunogen:
      • The antiserum was produced against synthesized peptide derived from human BRI3B. AA range:1-50
      • Specificity:
      • KG19 Polyclonal Antibody detects endogenous levels of KG19 protein.
      • Formulation:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • Source:
      • Polyclonal, Rabbit,IgG
      • Dilution:
      • WB 1:500 - 1:2000. IHC 1:100 - 1:300. IF 1:200 - 1:1000. ELISA: 1:20000. Not yet tested in other applications.
      • Purification:
      • The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
      • Concentration:
      • 1 mg/ml
      • Storage Stability:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • Other Name:
      • BRI3BP;KG19;BRI3-binding protein;I3-binding protein;Cervical cancer 1 proto-oncogene-binding protein KG19;HCCRBP-1
      • Observed Band(KD):
      • 27kD
      • Background:
      • tissue specificity:Most abundantly expressed in brain, liver and kidney.,
      • Function:
      • tissue specificity:Most abundantly expressed in brain, liver and kidney.,
      • Subcellular Location:
      • Mitochondrion outer membrane ; Multi-pass membrane protein .
      • Expression:
      • Most abundantly expressed in brain, liver and kidney (PubMed:11860200). Overexpressed in leukemia and lymphoma cell lines, as well as in various carcinomas (PubMed:17943721).
      • Products Images
      • Immunohistochemistry analysis of paraffin-embedded human brain tissue, using BRI3B Antibody. The picture on the right is blocked with the synthesized peptide.
      • Western blot analysis of lysates from RAW264.7 cells, using BRI3B Antibody. The lane on the right is blocked with the synthesized peptide.